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Abstract  
PURPOSE: The purpose of this study is to evaluate the prevalence of various concerns among 
left ventricular assist device (LVAD) patients and evaluate the effect of an educational video 
intervention on reducing those concerns in a single-center adult LVAD population. 
METHODS: A 15-point LVAD Concerns Scale was created to evaluate the prevalence of 
specific device-related concerns. An educational video was created to address the concerns 
presented in the LVAD Concerns Scale. Data collection took place from November 2018 to 
February 2019. A cross-sectional, pre- post-test implementation study design was used to both 
identify various device-related concerns that exist among LVAD patients and examine the 
effectiveness of an educational intervention on reducing patients’ device-related concerns.  
RESULTS: Of the available LVAD patients who met inclusion criteria, 30 were enrolled to 
participate. The designed LVAD Concerns Scale was found to have acceptable reliability. 
Participants’ LVAD-related concerns were significantly reduced following implementation of 
the LVAD Concerns Video.  
CONCLUSION: Implementation of an educational intervention tailored to address LVAD 
patients’ specific device-related concerns resulted in a statistically significant decrease in those 
concerns. With the disparity between the number of patients awaiting heart transplantation and 
the number of available donor hearts, LVADs are being used with increased frequency to treat 
advanced heart failure. However, available education is suboptimal. Further development of 
education is required to improve patient outcomes.  
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The Effect of an Educational Video on Device-Related Concerns in a Single-Center Left 
Ventricular Assist Device Population  
Introduction 
The prevalence of heart disease continues to climb, with over 28 million adults living 
with the condition (CDC, 2017).  Progression of the disease process leads to heart failure, a 
chronic, progressive, debilitating condition characterized by the heart’s inability to pump an 
adequate amount of blood and oxygen to meet the body’s needs (American Heart Association, 
2017). Heart failure affects an estimated 6.5 million adults in the United States (Heart Failure 
Society of America, 2019). Despite advances in cardiovascular risk prevention, the prevalence of 
heart failure continues to increase. It is estimated that more than 900,000 new patients are 
diagnosed with heart failure each year (Dillworth et al., 2018) and the prevalence of the disease 
is expected to increase to greater than 8 million people diagnosed by the year 2030 (Heart Failure 
Society of America, 2019). Heart disease is the leading cause of death for both men and women, 
estimated to contribute to 1 in every 4 deaths (CDC, 2017). Of those whose disease progresses to 
failure, half will die within 5 years (CDC, 2019; Casida et al., 2011). While heart failure cannot 
be cured, it can often be managed through strategies to improve symptoms. Those patients with 
advanced disease who are unable to be further medically managed may require advanced, 
invasive therapies. Historically, the treatment of choice for severe, advanced heart failure has 
been transplantation. However, the number of patients awaiting heart transplantation worldwide 
has doubled in the last 15 years (Prinzing et al., 2016), yet the number of available donor hearts 
has not increased at the same rate, creating a significant health disparity. In 2018, 314 patients 
died while awaiting heart transplantation and an additional 340 patients became too sick to 
transplant (U.S. Department of Health and Human Services, n.d.). Consequently, because of the 
lack of available donor hearts more than 600 patients suffered and were not transplanted. This 
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disparity has resulted in the use of mechanical circulatory support (MCS) devices with increasing 
frequency (American Heart Association, 2017).  
Left ventricular assist devices (LVADs) are the fastest growing treatment for advanced 
heart failure, with nearly 2,500 implantations per year in the United States (Kostick et al., 2018). 
From 2012 to 2016, there were 13, 279 LVADs implanted as a primary device (The Data and 
Clinical Coordinating Center University of Alabama Birmingham, 2017). An LVAD is a 
surgically implanted mechanical pump that attaches to the heart and functions to assist the heart 
in pumping by continuously pulling blood from the left ventricle and placing it into the aorta, 
thus imitating restoration of the physiologic function of the damaged left ventricle (Casida et al., 
2011). While these devices can improve survival rates, quality of life, and functional 
capacity in appropriately selected patients with end-stage heart failure (Verdoorn et al., 
2017; Iacovetto et al., 2014), they remain associated with considerable risks and require 
significant lifestyle changes post-implantation (Iacovetto et al., 2014; Allen et al., 2018; Metzger 
et al., 2016; Thompson et al., 2015). The complexity and invasiveness of these devices yield 
many concerns among patients and their caregivers, presenting providers with unique 
educational challenges when caring for patients who are considering or who have received an 
LVAD. 
 High quality educational materials are particularly important in the setting of active 
medical decision-making (Iacovetto et al., 2014) yet for many key decisions involving new, life-
prolonging technologies, education, consent, and shared decision-making processes are 
suboptimal (Allen et al., 2018). Patient decisions to undergo LVAD implantation are often 
made reflexively, quickly, and intuitively without understanding the LVAD in the larger context 
of treatment options (Bruce et al., 2015). As well, many patients do not see declining an LVAD 
as an option (Thompson et al., 2015). While many educational materials of various modalities 
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exist regarding LVAD therapy, the materials are written at a literacy level that exceeds the 
comprehension abilities of the average American and the content is substandard (Iacovetto et al., 
2014; Thompson et al., 2015). When reviewing the current educational materials available to 
LVAD patients and those considering LVAD implantation, a majority of the materials are 
informational and do not present alternative treatment options; are distributed by manufacturers, 
presenting a clear conflict of interest; describe the benefits of LVAD therapy with insufficient 
presentation of the risks; use outdated statistics; and are biased toward accepting LVAD therapy 
(Iacovetto et al., 2014; Thompson et al., 2015). There is an urgent necessity for decisional 
support for LVAD treatment due to poor patient understanding about the capabilities, lifestyle 
implications, and risks of LVADs (Kostick et al., 2018).  
Patient and caregiver education regarding complex medical therapies, such as LVAD 
implantation, is an area of continuing development (Iacovetto et al., 2014). The Centers for 
Medicare and Medicaid Services (CMS) emphasize the importance of patients and caregivers 
being equipped with the knowledge and support to make informed decisions about 
care (Verdoorn et al., 2017). Yet some discord exists in patients’ quality of life expectations 
pre- and post-implantation (Kitko et al., 2016), which may be partially attributed to unaddressed 
LVAD-related concerns and inadequate education to alleviate those concerns. Currently, there 
are limited evidence-based educational materials available that address specific concerns related 
to living with an LVAD. In patients with heart failure, nurse educator-delivered patient education 
prior to discharge results in improved outcomes, increased adherence, and reduced costs 
(Koelling et al., 2005). It is hypothesized that similar outcomes will be seen in patients implanted 
with LVADs. In order to develop educational materials that will adequately address specific 
LVAD-related concerns, it is essential to define those concerns. Evaluating specific device-
related concerns in LVAD patients is essential to understanding gaps in the LVAD-related 
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education provided to this patient population. Patients considering LVAD implantation often 
worry about becoming debilitated with the device and a burden to their families; the future with 
the device; disfigurement and altered body image; and how the device will change their lifestyle, 
relationships, and environment (Dillworth et al., 2018).  There is currently limited research on 
patients’ LVAD-related concerns and no research exists to evaluate outcomes following an 
educational intervention tailored towards addressing those concerns. Tailored educational 
materials may mitigate patients’ device-related concerns and improve their perceived quality of 
life following implantation. This project aims to describe specific LVAD-related concerns that 
exist among patients living with an LVAD and fill an educational gap by developing a video that 
addresses common concerns noted in clinical practice among this population.  
Purpose 
As LVADs continue to be implanted with increased frequency as a treatment modality 
for patients with end-stage heart failure, the urgent need for improved education addressing 
lifestyle considerations and concerns is heightened. The purpose of this study is to 
describe specific LVAD-related concerns and implement an educational video to address those 
concerns. Through a pre- and post-test implementation model, the effect of the educational 
intervention on specific device-related concerns is identified. The goal is to improve patient 
education regarding lifestyle considerations and concerns associated with living with an LVAD.  
Methods 
This study was a single-center, cross-sectional, pre- post-test design. The study aimed to 
identify various LVAD-related concerns and examine the effect of an educational video 
intervention on patients’ specific device-related concerns.  
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LVAD Concerns Scale 
Research has been done in the past regarding concerns among patients with implantable 
cardioverter-defibrillators (ICD). It is hypothesized that similar concerns may exist among 
patients with other life-prolonging, invasive therapies. Thus, using the ICD concerns scale as a 
model (Pedersen et al., 2005; Thylen et al., 2016), in combination with concerns noted in clinical 
practice among providers caring for LVAD patients, a 15-point concerns scale was created. This 
LVAD Concerns Scale is a Likert Scale scored from 0 to 4, with 0 being not concerned at all, 1 
being a little bit concerned, 2 being somewhat concerned, 3 being quite a bit concerned, and 4 
being very much concerned. See Figure 1 for full scale. The scale underwent revision from 
LVAD experts and a survey developer before it was finalized. This scale has demonstrated 
internal consistency with a Cronbachs a of 0.911.  
LVAD Concerns Educational Video  
An educational video was then created to address the various concepts in the LVAD 
Concerns Scale. The LVAD Coordinators along with a team of health education specialists at 
UK Healthcare aided in the video development to ensure that device-related concerns noted 
among LVAD patients in clinical practice and in the literature were addressed, and to ensure that 
the health literacy of the video was at a level that would be understood by all participants.  
Setting 
The UK HealthCare patient care enterprise is the largest system in the Lexington, KY 
area including four hospitals along with numerous other clinics, centers, and outreach locations 
across the state of Kentucky. Albert B. Chandler Hospital and the Gill Heart and 
Vascular Institute house the MCS department and LVAD program and is thus, the primary 
location of this study. Albert B. Chandler Hospital and the Gill Heart Institute provide services to 
patients all across the state of Kentucky, as well as the surrounding regions. Albert B. Chandler 
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Hospital is a 569-bed acute care hospital and is the only Level I trauma center in Central and 
Eastern Kentucky. The cardiothoracic surgery program at the Gill Heart and Vascular Institute 
provides specialized care for heart failure patients including cardiac-assist devices and heart 
transplantation. Currently, UK is the larger of two LVAD programs in the state of Kentucky. The 
Gill Heart and Vascular Institute first received the Joint Commission’s Gold Seal of Approval in 
2009 and has maintained the certification since that time, indicating its compliance with the Joint 
Commission’s national standards for healthcare quality and safety in LVAD care.   
Sample 
Patients included in the study were those that a.) have an implanted LVAD for the 
treatment of end-stage heart failure; b.) have had the LVAD implanted for at least 30 days; c.) 
are able to complete the three-question assessment following consent to ensure understanding of 
both the consent and study itself; and d.) are able to speak and write in English. Patients were 
excluded from the study if they were a.) less than 18; b.) institutionalized or reside in an 
extended care nursing facility; and/or c.) unable to complete the three-question assessment 
indicating understanding of the consent and study. The patient population of interest are patients 
diagnosed with end-stage heart failure who had been implanted with an LVAD, under the care of 
the LVAD team at UK HealthCare. Data collection took place from November 2018 to February 
2019. All patients implanted were reviewed for eligibility with only those meeting inclusion 
criteria referred by the LVAD coordinators and contacted for potential participation. Thirty 
patients (n=30) met inclusion criteria and consented to participate in the study. Of note, one 
participant was blind and therefore was unable to watch the video and complete the post-video 
LVAD-concerns scale. This resulted in a post-video sample size of 29 participants (n=29). 
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Data Collection  
Approval from the University of Kentucky Institutional Review Board (IRB) was 
obtained prior to the collection of data. The LVAD Coordinators at UK Healthcare referred all 
patients for participation to the research team. A project member, either the primary investigator 
(PI) or co-investigator (CO-I), then contacted those patients referred by the LVAD Coordinators 
to identify interest in participation. Either the PI or CO-I then set up in-person meetings with 
those patients who agreed to participate to provide a full explanation of the study. In-person 
meetings were set up at a location of the patient’s choosing, which included patient homes, the 
Gill Heart and Vascular Clinic, and inpatient at UK Albert B. Chandler Hospital. All meetings 
took place in private, with just the PI and/or CO-I present with the patient. The presence of 
family or other individuals was left up to the participant. If other individuals accompanied the 
participant, the PI and/or CO-I ensured that the participant did not enlist the help or opinions of 
those individuals throughout the duration of the study. The purpose and procedures of the 
study were described, and all questions answered prior to obtaining signed informed consent. 
Potential participants were assured that they would not incur any additional costs because of their 
participation in the study. As well, potential participants were advised that they may withdraw 
from participation at any time. Following explanation of the consent and answering any 
questions, potential participants were asked to answer three questions in order to indicate their 
understanding of the consent and the study. If participants were unable to answer all three 
questions correctly, they were remediated again through the consent form. After remediation, the 
patient was asked to answer the three questions again. If they were unable to answer correctly, 
they were told that they are not eligible for the study. This did not occur throughout the duration 
of this study. A copy of each patient’s informed consent was kept on file and separate from all 
other identifiable data collection. A copy of the signed consent form was also provided to the 
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patient at the time of enrollment. Each data sheet was coded with a unique participant number 
and stored in a locked file cabinet in a locked research office that is key entry only. Data were 
collected using paper questionnaires and then transferred to the REDCap system, a secure web-
based application for building and managing databases. All REDCap data are stored on a secure 
web server located behind a firewall on the University of Kentucky network. A trained data 
manager monitored data collection. Demographic data was obtained via a survey that 
participants filled out prior to the questionnaire along with review of patients’ medical records. 
Patients who agreed to participate and completed the study were given twenty dollars in the form 
of a check that was mailed to an address provided by the patient.  
 Data Analysis  
 The study was completed using a cross-sectional design. Data related to LVAD concerns, 
demographic data, and other survey related information were self-reported; medical history, lab 
vales, and indication for LVAD were obtained from the participants medical records. To describe 
patient characteristics, means ± standard deviations were used for continuous level variables and 
frequency and proportions were used for categorical variables. In order to evaluate and compare 
the scores from each individual question on the LVAD Concerns Scale as well as total scores, a 
Wilcoxon Signed Ranks Test was used. This is a more robust test for small sample sizes and 
non-normally distributed data. Thus, given the sample size of 30 participants in this study and an 
abnormal data distribution, this test was chosen.  
Results 
Sample Characteristics 
 A total of 30 LVAD patients agreed to participate. The mean age was 57 years, with the 
majority of patients being Caucasian (90%) and male (76.7%). Half of the sample size was 
married, with the other half being either single (23.3%) or divorced/separated/widowed (26.7%). 
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All patients had a New York Hospital Association (NYHA) Classification of either III or IV, 
with a majority having a NYHA Classification of IV (70%). Additionally, a majority of 
participants had their LVAD implanted as destination therapy (DT) (63.3%). On average, 
participants had their LVADs implanted for 702 days, with a range of 34 to 2472 days. See Table 
1 for a full list of demographic data.  
Outcomes 
 Implementation of the LVAD Concerns Video resulted in a significant reduction in 
LVAD related concerns. Using the Wilcoxon Signed Ranks Test, mean scores pre- and post-
video were 22 ± 14 and 17 ± 13, respectively (p-value 0.002). This indicates that the LVAD 
Concerns Video significantly reduced the overall concerns of participants. Refer to Table 2 for a 
comparison of overall concern pre- and post-video implementation.   
Initially, participants were most concerned about being a burden to their family (2.07 ± 
1.46), the LVAD abruptly stopping (2.07 ± 1.5), having no warning the LVAD would malfunction 
(2.00 ± 1.66), and not being able to do the things that they love (1.80 ± 1.32). Participants were 
least concerned about exercise causing the LVAD to malfunction (0.83 ± 0.99) and the symptoms 
or pain associated with the LVAD (0.90 ± 0.92) on the pre-video assessment. The most significant 
reduction in concerns pre- and post-video was seen in participants’ concerns about traveling with 
their LVAD, 1.57 ± 1.36 pre-vide to 0.76 ± 0.99 post-video (p-value 0.001). Five other concerns 
on the scale resulted in a statistically significant reduction in participants’ concerns following 
implementation of the LVAD Concerns Video, which included concerns about the LVAD 
abruptly stopping (p- value 0.007), having no warning the LVAD is going to stop working (p-
value 0.009), making love(p-value 0.010), working too hard (p-value 0.01), and the battery dying 
(p=0.032). Refer to Table 3 for a full breakdown of concern prevalence pre- and post-video 
implementation.   
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Discussion 
 This study aimed to both identify specific LVAD-related concerns and evaluate the effect 
of an educational video intervention on reducing those concerns. Education across the spectrum 
of pre- to post-implantation is inadequate and patients are often left with a plethora of 
unaddressed concerns, leading to a discrepancy in their pre- and post-implantation expectations 
(Iacovetto et al., 2014; Kitko et al., 2016). Overall, implementation of the LVAD Concerns 
Video resulted in a statistically significant reduction in participants’ device-related concerns.  
Many of the points from the LVAD Concerns Scale that most participants worried about 
were related to the device itself and the possibility of the device failing. Patients’ lives depend on 
the device functioning appropriately. A majority of participants had been implanted months to 
years prior to participation and had not experienced any malfunction of the device, yet many 
were still concerned that their device would stop functioning abruptly and that they would have 
no warning that their device would malfunction. The LVAD Concerns Video significantly 
reduced participants’ concerns regarding the LVAD abruptly stopping and having no warning the 
LVAD would malfunction, indicating that previous patient education may not have adequately 
addressed these points.   
Participants also had significant concerns about being a burden to their family. Part of the 
screening process prior to LVAD implantation evaluates patients’ support systems. It is expected 
that information and knowledge will be provided to both potential LVAD recipients and their 
caregivers during the decision process regarding the lifestyle adjustments that will take place 
following implantation, including the dependence that the LVAD recipient will have on their 
family for appointment follow-up, medication management, dressing changes, etc. This pre-
implantation evaluation is designed to ensure that the recipient has a dependable and willing 
caregiver to assist them in their day-to-day needs once implanted. However, a majority of 
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patients were still concerned about being burdensome to their caregivers and their family. While 
a reduction in these concerns was noted following implementation of the video, this reduction 
was not statistically or clinically significant. These concerns may be inherent to LVAD patients. 
People who were once independent now rely heavily on those around them, and education may 
not resolve those concerns. However, discussions with patients and caregivers about this topic 
should be ongoing and education should adequately explore the lifestyle implications of LVAD 
implantation on both the patient and caregiver.  
Concerns surrounding the inability to do the things that the patients love were also rated 
amongst the highest concerns on the scale. These devices require significant lifestyle changes 
and the majority of patients are not able to live the lifestyle that they lived prior to implantation. 
Many activities are restricted, whether due to functional capacity following implantation or being 
hooked to a mechanical device at all times. This can potentially distress patients if they are not 
adequately educated on the lifestyle adjustments that will result following LVAD implantation. 
The participants had all been living with their LVAD for more than 30 days, with most 
participants having their LVAD for almost two years, yet the inability to do the things that they 
love remained among one of the highest rated concerns. The LVAD Concerns Video did not 
significantly alter participants’ concerns related to their ability to do the things that they love. 
This highlights the necessity of adequate and thorough education regarding lifestyle adjustments 
and implies that this education may better prepare patients if given prior to implantation so that 
patients can be equipped for life following LVAD implantation.  
The point with the most reduction post-video implementation was that regarding 
participants’ concerns about traveling. While this was not one of the highest rated concerns pre-
video, it had the most statistically significant reduction post-video. This emphasizes a lack of 
knowledge regarding the ability to travel with an LVAD, and an inadequacy of current 
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educational materials to address traveling with an LVAD.  There was no difference in concerns 
regarding the future with the LVAD pre- and post-video. This is likely due to the length of 
LVAD therapy of participants. A majority of participants had been living with their LVAD for a 
substantial amount of time, so the idea of living with a mechanical device was not new. As well, 
a majority of participants were implanted as destination therapy, so the possibility of 
transplantation was not a consideration or potential concern related to their future.  
Overall, none of the concerns on the LVAD Concerns Scale had mean scores higher than 
2.07 pre-video implementation. This relatively low average rating of the concerns is likely due to 
the length of time that the participants had been living with their LVAD. The concerns of LVAD 
patients may decrease over time as they adjust to life with an LVAD and fall into a routine of 
normalcy living with an implanted mechanical device. Patients’ concerns during the decision 
process, when considering LVAD implantation, or immediately post-implantation are likely 
much higher than they are once they have been living with their device for a considerable 
amount of time. Thus, if this study were replicated at these earlier timepoints, the results would 
likely yield higher mean scores and the educational intervention may produce greater 
significance in reducing those concern scores.  
This study highlights that current educational materials available to LVAD patients are 
suboptimal and illustrates that an educational intervention specifically tailored to address the 
concerns of LVAD patients significantly reduces those concerns. Patients who are healthier at 
baseline report a lower quality of life following LVAD implantation (Stehlik et al., 2017). This 
may be related to specific LVAD concerns. These patients are more functional prior to 
implantation, and thus, their lifestyle changes post-implantation are more drastic, creating 
discord between their expectations pre- and post-implantation. This video, along with other 
educational materials that aim to address concerns, may improve the quality-of-life of patients by 
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addressing their concerns and preparing them for the lifestyle changes that will result from 
LVAD implantation.  
Limitations 
 Several limitations were noted in the design of this study. First, the study took place at a 
single LVAD center. Thus, the results may solely reflect the concerns of patients at our center 
and not be inclusive of those at other centers. The sample size was also small. With only 30 
participants, results may have differed if more participants were included. Both of these factors 
limit the generalizability of the study. As well, the LVAD Concerns Scale was new and 
previously untested prior to this study. Though the scale was found to have acceptable reliability, 
it is unclear whether this scale would accurately and comprehensively capture the concerns of 
LVAD patients across various institutions and regions. Finally, the LVAD Concerns Video was 
created based off of the LVAD Concerns Scale, thus it may not systematically address the 
concerns of those patients at other institutions and in various regions. Each institution manages 
their LVAD patients differently, thus the video may solely reflect educational points that pertain 
to the population of patients at our center.  
Conclusion 
Patients and caregivers are not equipped with the knowledge or education necessary to 
make informed decisions regarding invasive, life-sustaining therapies, such as LVAD 
implantation, or to prepare them for living with their device. Future research should evaluate 
how patients’ concerns change from pre-implantation to post-implantation, specifically assessing 
how patients’ concerns may reduce over time. This would allow education to be tailored to 
patients based on where they are on the continuum of LVAD therapy. As well, this study may be 
replicated pre-implantation as part of a decision-aid or immediately post-implantation as part of 
discharge teaching. Both of these are critical times for patients and caregivers. Adequate 
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education at these timepoints is necessary to ensure that patients are making informed decisions, 
have improved outcomes, have realistic expectations, and have an enhanced quality of life. 
Caregivers play a vital role in this population, so I also recommend a similar study be conducted 
to address the concerns of caregivers of patients with LVADs. Additionally, I recommend 
evaluating palliative care’s role in this population and the effect that this team can have on the 
concerns of patients with LVADs. Finally, further education needs to be developed to address 
other areas of LVAD therapy and should be evaluated for its adequacy.  
The goal of this study was to identify specific device-related concerns among LVAD 
patients and evaluate the effect of an educational video intervention on reducing those concerns. 
The LVAD Concerns Scale was noted to have acceptable reliability in identifying patients’ 
device-related concerns and the LVAD Concerns Video significantly reduced patients’ concerns. 
Incorporation of this video into clinical education may aid in aligning pre- and post-implantation 
expectations and improve patients’ quality-of-life following LVAD implantation. This study 
confirms the inadequacy of current educational practices and emphasizes the need for improved 
materials, highlighting a reduction in concerns with implementation of an educational 
intervention specifically tailored to address concerns of LVAD patients. Further development of 
educational materials specifically tailored to LVAD patients could transform the patient 
experience and significantly improve patient outcomes.  
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Table 1. Demographic Data 
Demographic Data 
  Full Sample (N=30)  
Age (years)  57 (16)   
Sex: male, n(%)  23 (76.7)  
Race n(%)    
     White  27 (90)  
     Black or other minority  3 (10)  
Marital status    
     Single  7 (23.3)  
     Married  15 (50)  
     Divorced/Separated/Widowed  8 (26.7)  
NYHA classification, n(%)(n=29)    
     III  8 (26.7)  
     IV  21(70)  
Intermacs Profile, n(%)    
     1  4 (13.3)  
     2  6 (20)  
     3  17 (56.7)  
     4  2 (6.7)  
Indication, n(%)    
     Destination Therapy  19 (63.3)  
     Bridge to Transplant  11 (36.7)  
ICD Therapy (yes), n(%) (n=29)  25 (83.3)  
Days with LVAD Therapy  702 (589)  
Range of LVAF Therapy (in days) 34 - 2472 
Pump Exchange (yes), n(%) (n=29)  3 (10)  
EuroQOL total score  8 (2)  
MoCa total score(n=29)  23 (4)  
Newest Vital Sign total score (n=28)  2 (2)  
MPSS total score (n=29)  72 (17)  
CAS-R total score  30 (6)  
LVAD Concerns total score  22 (14)  
PHQ-9 total score  7 (5)  
BSI Anxiety Subscale total score (n=29)  4 (5)  
IDAS total score  64 (8)  
Legend: Data are shown as mean (SD), except as noted. NYHA- New York Hospital Association 
Class, ICD- Implantable cardioverter defibrillator, LVAD- left ventricular assist device, EuroQOL- 
European quality of life measurement, MoCa- Montreal cognitive assessment, MPSS- 
multidimensional perceived social support, CAS-R- Control attitudes scale revised, PHQ-9- Patient 
health questionnaire-9, BSI- Brief symptom inventory, IDAS- Implanted device adjustment scale.  
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Table 2. Comparison of Concerns Pre- and Post-Video Implementation  
 
Comparison of Concerns Pre- and Post-Video Implementation  
 Sample Total Scores (Mean ± SD) 
Pre-Video N=30 22 ± 14 
Post-Video N=29 17 ± 13 
P-value overall = 0.002 
 
 
Table 3. Comparison of Concerns Pre- and Post-Video Implementation by Question  
 
Comparison of Concerns Pre- and Post-Video Implementation by Question  
 Pre-Video Post-Video P-Value 
Q1: Battery Dying 1.43 ± 1.28 0.86 ± 1.06 0.032 
Q2: LVAD abruptly 
stops working 
2.07 ± 1.51 1.45 ± 1.27 0.007 
Q3: Alarms going off, 
not knowing how to 
respond 
1.43 ± 1.50 0.90 ± 1.08 0.058 
Q4: Exercise causing 
LVAD malfunction 
0.83 ± 0.99 0.86 ± 1.30 0.954 
Q5: Activities/hobbies 
causing LVAD 
malfunction 
1.03 ± 1.25 1.00 ± 1.31 0.793 
Q6: Heart condition 
getting worse 
1.67 ± 1.35 1.41 ± 1.27 0.294 
Q7: Not being able to 
do things I love 
1.80 ± 1.32 1.62 ± 1.29 0.632 
Q8: Traveling 1.57 ± 1.36 0.76 ± 0.99 0.001 
Q9: Working too hard 
causing LVAD 
malfunction 
1.40 ± 1.30 0.79 ± 1.11 0.011 
Q10: Making love 
causing LVAD 
malfunction 
1.20 ± 1.45 0.66 ± 1.11 0.010 
Q11: Having no 
warning LVAD will 
malfunction 
2.00 ± 1.66 1.14 ± 1.33 0.009 
Q12: Symptoms/pain 
associated with LVAD 
0.90 ± 0.92 0.72 ± 0.88 0.330 
Q13: Being a burden 
to family 
2.07 ± 1.46 1.69 ± 1.37 0.083 
Q14: Not being able to 
work/take part in 
activities/hobbies 
1.57 ± 1.38 1.38 ± 1.21 0.327 
Q15: The future 1.27 ± 1.41 1.28 ± 1.28 1.000 
  
 
 
LVAD-RELATED CONCERNS   
 
 
21 
Figure 1. LVAD Concerns Scale 
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